Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL

Clinical trial NCT04448834 · WITHDRAWN

Trial details

NCT number: NCT04448834
Sponsor: Dorothy Sipkins, MD, PhD
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia

Start date: 2022-01-01
Primary completion: 2023-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.